Inicio・Lista de Acciones・CareDx Inc

CareDx Inc

Cerrado

SectorSanidad

46.28 2.16

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

45.08

Máximo

45.5

Métricas clave
By Trading Economics
Ingresos	108M 111M
Ventas	14M 132M
P/B Media del Sector	22.522 57.002
BPA	0.17
Margen de beneficios	83.848
Empleados	761
EBITDA	-3.8M 4.3M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+5.36% upside

Dividendos
By Acuity
Próximas Ganancias	3 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	557M 2.4B
Apertura anterior	44.12
Cierre anterior	46.28

CareDx Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 ago 2026, 20:02 UTC

CareDx Inc shares are lower today amid notable volatility. A recent report showed an unexpected drop in U.S. retail sales, impacting broader market sentiment.

12 ago 2026, 19:36 UTC

CareDx Inc. shares are lower today, reflecting a slight decline since Tuesday's close, despite earlier rebounding from a session low.

11 ago 2026, 23:41 UTC

CareDx Inc shares advanced in after-market trading, reflecting notable gains since Tuesday's close. The stock remains well above its 20-day moving average.

10 ago 2026, 23:46 UTC

CareDx Inc shares are higher in after-market hours, trading significantly above their 20-day moving average and near the upper end of their one-month range.

7 ago 2026, 20:06 UTC

CareDx Inc shares are higher today, recovering from an early dip. The stock has gained significantly since Thursday amid a decline in Treasury yields.

5 ago 2026, 19:46 UTC

Shares of CareDx Inc. are lower today amid unusual volatility, reflecting a broader market sentiment influenced by disappointing employment data from ADP.

4 ago 2026, 21:36 UTC

CareDx Inc shares are higher in after-market trading, reflecting a broader U.S. stock rally amid declining crude oil prices easing inflation concerns.

3 ago 2026, 20:02 UTC

News

CareDx Inc shares rise following a rating upgrade to Buy from Craig-Hallum and a new price target of $64, up from $35.

31 jul 2026, 23:06 UTC

News

CareDx shares are lower in after-market hours despite a 52% revenue increase to $132 million and raised full-year guidance to $490 million-$500 million.

30 jul 2026, 23:41 UTC

News

CareDx Inc reported second-quarter revenue of $132 million, exceeding estimates. Following strong results and raised guidance, shares are higher in after-market trading.

29 jul 2026, 19:56 UTC

CareDx Inc shares are lower, continuing a six-session decline amid rising crude oil prices and inflation concerns affecting broader market sentiment.

27 jul 2026, 19:16 UTC

News

CareDx Inc is trading lower today, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

22 jul 2026, 19:16 UTC

CareDx Inc shares are lower today with no specific news identified. Broader market sentiment is affected by rising crude oil prices amid geopolitical tensions.

20 jul 2026, 18:53 UTC

News

CareDx shares are lower as Director Valantine Hannah sold 28,779 shares at prices between $36.14 and $36.55, raising investor concerns.

Comparación entre iguales

Cambio de precio

CareDx Inc previsión

Precio Objetivo

By TipRanks

5.36% repunte

Estimación a 12 Meses

Media 47.75 USD 5.36%

Máximo 64 USD

Mínimo 21 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para CareDx Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.